𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ziprasidone monotherapy in bipolar II depression: An open trial

✍ Scribed by Michael R. Liebowitz; Ester Salmán; Arnold Mech; David Dunner; Ann E. Johnson; Jamil Akhtar; Rajiv Pratap

Book ID
113666693
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
158 KB
Volume
118
Category
Article
ISSN
0165-0327

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Olanzapine monotherapy for acute depress
Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial
✍ William V. Bobo; Richard A. Epstein; Richard C. Shelton 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract We evaluated the efficacy, tolerability, and safety of olanzapine monotherapy in 20 adult patients with bipolar I or II disorder, depressed phase. Patients received open‐label olanzapine monotherapy (mean modal dose, 15 mg/day) for 8 weeks. Assessments of psychopathology (Montgomery–Asb